|

Multiple Sclerosis Clinical Trials in Maryland

31 recruiting studies across 1 city

Browse by City

Baltimore
31 trials

All Trials in Maryland

Phase
Trial Phase Dist.
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple SclerosisPhase 3<1 mi
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—<1 mi
Confirmatory Trial for Alleviating Fatigue in Multiple SclerosisN/A<1 mi
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable CancerPhase 1<1 mi
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe EpilepsyPhase 1/2<1 mi
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis (ALS)Phase 1<1 mi
Study of COYA 302 for the Treatment of ALSPhase 2<1 mi
Ketamine for Multiple Sclerosis FatiguePhase 2<1 mi
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis PatientsPhase 2<1 mi
Solriamfetol for the Treatment of Multiple Sclerosis FatiguePhase 2<1 mi
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisPhase 39 mi
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabPhase 39 mi
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Phase 326 mi
TSC Biosample Repository and Natural History Database—30 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesPhase 232 mi
Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal LeukoencephalopathyPhase 134 mi
Pathological Basis of MRI Signal Changes in Multiple Sclerosis—34 mi
Study of Skin Tumors in Tuberous Sclerosis—34 mi
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)Phase 1/234 mi
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System—34 mi
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis PlaquesPhase 234 mi
Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)—34 mi
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)—34 mi
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisPhase 334 mi
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring—34 mi
Genes and Environment in Multiple Sclerosis—34 mi
Study of the Disease Process of Lymphangioleiomyomatosis—34 mi
Role of Genetic Factors in the Development of Lung Disease—34 mi
An Open-label Study of AZD0120 in Adults With Multiple SclerosisPhase 136 mi
AMX0114 in Adult Participants With Amyotrophic Lateral SclerosisPhase 136 mi
Ocrelizumab Discontinuation in Relapsing Multiple SclerosisPhase 436 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.